Surveillance for Adverse Events After COVID-19 mRNA Vaccination

No.13731718 ViewReplyOriginalReport
Surveillance for Adverse Events After COVID-19 mRNA Vaccination

>analysis of surveillance data from 6.2 million persons who received 11.8 million doses of an mRNA vaccine, event rates for 23 serious health outcomes were not significantly higher (...) after vaccination

>This analysis found no significant associations between vaccination with mRNA COVID-19 vaccines and selected serious health outcomes

https://jamanetwork.com/journals/jama/fullarticle/2784015